Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Galapagos N.V. (OP: GLPGF )

26.26 +1.60 (+6.49%)
Streaming Delayed Price Updated: 12:38 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 29
Open 26.26
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 24.66
Today's Range 26.26 - 26.26
52wk Range 22.60 - 36.21
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Galapagos' Filgotinib Shows Clinical Benefit In Ulcerative Colitis Non-Responding Patients
Galapagos NV (NASDAQ: GLPG) announced results of two post-hoc analyses from the SELECTION and SELECTION LTE studies of filgotinib for active ulcerative colitis (UC... 
Via Benzinga
Galapagos Assumes Responsibility Of Late-Stage Filgotinib Trial In Crohn's Disease
Galapagos NV (NASDAQ: GLPG) has randomized the last patient into the DIVERSITY Phase 3 study of filgotinib in the induction and maintenance of remission in... 
Via Benzinga

Performance

YTD
-27.48%
-27.48%
1 Month
+6.49%
+6.49%
3 Month
+6.49%
+6.49%
6 Month
+16.19%
+16.19%
1 Year
-27.48%
-27.48%

More News

Read More
Galapagos' Long-Serving CEO Onno Van De Stolpe To Exit After R&D Setbacks
Via Benzinga
Galapagos' Another Psoriasis Candidate Shows Efficacy, Safety Profile In Mid-Stage Study
Via Benzinga
Galapagos Shares Drop As SIK Inhibitor Fails To Show Positive Outcomes In Ulcerative Colitis, Rheumatoid Arthritis Patients
Via Benzinga
Galapagos Drops Early Metabolic & Osteoarthritis Programs, Reorganizes R&D Efforts
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.